Administration of cationic liposomal curcumin in combination with STAT3 siRNA resulted in decreased growth of B16-F10 mouse melanoma cells in culture and tumor reduction in C57BL/6 mice injected with B16-F10 cells when compared with the groups treated with the individual agents [49]. Here, STAT3 is linked to melanoma.